Benzodiazepines (Psy and mixed indications) updated on 02-10-2025

Severe cognitive developmental delay (Mental retardation) (> 6 years old)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S15459
R63563
Bjørk - Clonazepam (Mixed indications), 2022 Diagnosis of intellectual disability (ID): mild ID (F70), moderate ID (F71), severe ID (F72), and profound ID (F73) - Median follow up clonazepam 9.5 (5.5-13.9) years old during pregnancy (anytime or not specified) population based cohort retrospective unexposed (general population or NOS) Adjustment: Yes BZD Coexposure: No (among antiseizure medications) 1.76 [1.06;2.92] 15/1,182   16,384/4,463,879 16,399 1,182
ref
Total 1 studies 1.76 [1.06;2.92] 16,399 1,182
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Bjørk - Clonazepam (Mixed indications), 2022Bjørk - Clonazepam, 2022 1 1.76[1.06; 2.92]16,3991,1820%ROB confusion: moderateROB selection: lowROB classification: moderateROB missing: lowROB mesure: criticalROB reporting: moderate0.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Mixed indications;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.76[1.06; 2.92]16,3991,182 -NABjørk - Clonazepam (Mixed indications), 2022 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.76[1.06; 2.92]16,3991,182 -NABjørk - Clonazepam (Mixed indications), 2022 1 Tags Adjustment   - Yes  - Yes 1.76[1.06; 2.92]16,3991,182 -NABjørk - Clonazepam (Mixed indications), 2022 1 BZD Coexposure   - No (among antiseizure medications)  - No (among antiseizure medications) 1.76[1.06; 2.92]16,3991,182 -NABjørk - Clonazepam (Mixed indications), 2022 1 All studiesAll studies 1.76[1.06; 2.92]16,3991,182 -NABjørk - Clonazepam (Mixed indications), 2022 10.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.76[1.06; 2.92]16,3991,182 -NABjørk - Clonazepam (Mixed indications), 2022 10.510.01.0